Search Results - "Phillips, Patrick Peter John"

Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial by Kritski, Afranio, Oliveira, Maria Martha, Almeida, Isabela Neves de, Ramalho, Daniela, Andrade, Monica Kramer de Noronha, Carvalho, Monica, Miranda, Pryscila Fernandes Campino, Dalcolmo, Margareth Pretti, Braga, Jose Ueleres, Brígido, Tania, Mesquita, Eliene, Dias, Claudia, Gambirasio, Aglae, Souza Filho, Joao Baptista, Detjen, Anne, Phillips, Patrick Peter John, Langley, Ivor, Fujiwara, Paula, Squire, Stephen Bertel

“…Rapid molecular methods such as the line probe assay (LPA) and Xpert® MTB/RIF assay (Xpert) have been recommended by the World Health Organization for…”
Get full text

DOOR/RADAR: A Gateway Into the Unknown? by Phillips, Patrick Peter John, Morris, Tim Peter, Walker, Ann Sarah

Get full text

Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse by Ntinginya, Nyanda Elias, Bakuli, Abhishek, Mapamba, Daniel, Sabiiti, Wilber, Kibiki, Gibson, Minja, Lilian Tina, Kuchaka, Davis, Reither, Klaus, Phillips, Patrick Peter John, Boeree, Martin Johan, Gillespie, Stephen H, Hoelscher, Michael, Heinrich, Norbert

“…Abstract Bacterial killing in patients with tuberculosis (TB) relapse was compared to that in patients achieving cure, measured by TB molecular bacterial load…”
Get full text

DOOR/RADAR: A Gateway Into the Unknown?: Table 1 by Phillips, Patrick Peter John, Morris, Tim Peter, Walker, Ann Sarah

Get full text

Biomarkers for tuberculosis disease activity, cure, and relapse by Phillips, Patrick Peter John, Davies, Geraint R, Mitchison, Denis A

Get full text

Biomarkers for tuberculosis disease activity, cure, and relapse/Authors' reply by Phillips, Patrick Peter John, Davies, Geraint R, Mitchison, Denis A, Wallis, Robert S, Doherty, T Mark, Zumla, Alimuddin

Get full text

Prognostic and surrogate markers for outcome in the treatment of pulmonary tuberculosis by Phillips, Patrick Peter John

“…Phase III trials for new tuberculosis treatment regimens require large numbers of participants and can take over five years to complete. A surrogate marker for…”
Get full text